Publications by authors named "Niko Marx"

Claim this Profile
C
Compelling evidence for SGLT2 inhibitors and GLP-1 receptor agonists as first-line therapy in patients with diabetes at very high/high cardiovascular risk.
Niko Marx, Peter J Grant, Francesco Cosentino

Eur Heart J· January 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Peroxisome proliferator-activated receptors.
Ouliana Ziouzenkova, Stephane Perrey, Niko Marx, Daniel Bacqueville, Jorge Plutzky

Curr Atheroscler Rep· January 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis